Učitavanje...
What Occurs in the Other 20% of Cancer Patients with Chemotherapy-Induced Nausea and Vomiting (CINV)? A Single-Institution Qualitative Study
PURPOSE: Despite recent advances in prophylaxis and management, 20% of patients who receive moderately to severely emetogenic chemotherapy continue to experience nausea and vomiting. Relying on patients’ own words, this study sought to capture and characterize the lived experience with chemotherapy-...
Spremljeno u:
| Izdano u: | Support Care Cancer |
|---|---|
| Glavni autori: | , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2018
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6309746/ https://ncbi.nlm.nih.gov/pubmed/29938306 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-018-4323-x |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|